[HTML][HTML] Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer
WL Johnston, CN Catton, CJ Swallow - BMC urology, 2019 - Springer
Background Patients with newly diagnosed non-metastatic prostate adenocarcinoma are
typically classified as at low, intermediate, or high risk of disease progression using blood …
typically classified as at low, intermediate, or high risk of disease progression using blood …
[HTML][HTML] Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer
WL Johnston, CN Catton, CJ Swallow - BMC Urology, 2019 - ncbi.nlm.nih.gov
Background Patients with newly diagnosed non-metastatic prostate adenocarcinoma are
typically classified as at low, intermediate, or high risk of disease progression using blood …
typically classified as at low, intermediate, or high risk of disease progression using blood …
Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer.
WL Johnston, CN Catton, CJ Swallow - BMC Urology, 2019 - go.gale.com
Background Patients with newly diagnosed non-metastatic prostate adenocarcinoma are
typically classified as at low, intermediate, or high risk of disease progression using blood …
typically classified as at low, intermediate, or high risk of disease progression using blood …
Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer
WL Johnston, CN Catton, CJ Swallow - BMC Urology, 2019 - search.proquest.com
Background Patients with newly diagnosed non-metastatic prostate adenocarcinoma are
typically classified as at low, intermediate, or high risk of disease progression using blood …
typically classified as at low, intermediate, or high risk of disease progression using blood …
[引用][C] Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer
WL Johnston, CN Catton, CJ Swallow - BMC Urology (Web), 2019 - jglobal.jst.go.jp
Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason
score 7 prostate cancer | Article Information | J-GLOBAL Art J-GLOBAL ID:202002223331857365 …
score 7 prostate cancer | Article Information | J-GLOBAL Art J-GLOBAL ID:202002223331857365 …
Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer.
WL Johnston, CN Catton, CJ Swallow - BMC Urology, 2019 - europepmc.org
Background Patients with newly diagnosed non-metastatic prostate adenocarcinoma are
typically classified as at low, intermediate, or high risk of disease progression using blood …
typically classified as at low, intermediate, or high risk of disease progression using blood …
[PDF][PDF] Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer
WL Johnston, CN Catton, CJ Swallow - 2019 - scholar.archive.org
Background: Patients with newly diagnosed non-metastatic prostate adenocarcinoma are
typically classified as at low, intermediate, or high risk of disease progression using blood …
typically classified as at low, intermediate, or high risk of disease progression using blood …
[HTML][HTML] Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer
WL Johnston, CN Catton, CJ Swallow - BMC Urology, 2019 - bmcurol.biomedcentral.com
Patients with newly diagnosed non-metastatic prostate adenocarcinoma are typically
classified as at low, intermediate, or high risk of disease progression using blood prostate …
classified as at low, intermediate, or high risk of disease progression using blood prostate …
Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer
WL Johnston, CN Catton, CJ Swallow - BMC urology, 2019 - pubmed.ncbi.nlm.nih.gov
Background Patients with newly diagnosed non-metastatic prostate adenocarcinoma are
typically classified as at low, intermediate, or high risk of disease progression using blood …
typically classified as at low, intermediate, or high risk of disease progression using blood …
Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer
WL Johnston, CN Catton, CJ Swallow - tspace.library.utoronto.ca
Background Patients with newly diagnosed non-metastatic prostate adenocarcinoma are
typically classified as at low, intermediate, or high risk of disease progression using blood …
typically classified as at low, intermediate, or high risk of disease progression using blood …